ENTITY
Lepu Biopharma

Lepu Biopharma (2157 HK)

51
Analysis
Health CareChina
Lepu Biopharma Co Ltd operates as a biopharmaceutical company focusing on oncology therapeutics. The Company serves the unmet medical needs of cancer patients. Lepu Biopharma combines in-house research, development, and strategic collaborations to strengthen in-house manufacturing, and commercialize pipeline products through sales and marketing.
more
Refresh
09 Mar 2022 11:29

Jinmao Property Services IPO Trading - Expect a Modest Debut with Low Liquidity

Jinmao Property Services (816 HK) raised around US$105m in its Hong Kong IPO. In this note, we will look at the trading dynamics and current...

Logo
258 Views
Share
27 Feb 2022 07:47

ECM Weekly (27th Feb 2022) - LIC, SBI Sumishin, Farm Fresh, Yunkang, Shanghai Pulse, Jinmao, IDP Edu

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
292 Views
Share
25 Feb 2022 10:16

Jinmao Property Services IPO - Premium Asking Valuation and Cornerstones Took up 80% of Deal

Jinmao Property Services (JM HK) is looking to raise around US$105m in its Hong Kong IPO. In this note, we will look at deal dynamics, assumptions,...

Logo
359 Views
Share
bearishYunkang Group
24 Feb 2022 14:14

Yunkang Group Pre-IPO - Would Need to Prove Itself Post-COVID

Yunkang Group (YK HK) is looking to raise about US$200m in its upcoming Hong Kong IPO. While it has managed to grow its on-site centers, it has to...

Logo
280 Views
Share
22 Feb 2022 11:37

Lepu Biopharma (乐普生物科技) IPO Trading: High Share Concentration

We provide an update on latest information on Lepu Biopharma prior to debut tomorrow. Subscription is poor and the shares are highly concentrated.

Logo
169 Views
Share
x